Individuals with serious mental illness (SMI) who are prescribed antipsychotics are at risk for developing tardive dyskinesia (TD), a movement disorder that causes a range of repetitive movements outside of an individual’s control that can significantly affect quality of life.
Although screening tools such as the Abnormal Involuntary Movement Scale (AIMS) have long been available, screening remains inconsistent across care settings. NASMHPD is conducting a survey of mental health providers and systems leaders to better understand barriers and facilitators to abnormal involuntary movement screening and ultimately support timely intervention, informed treatment decisions, and improved quality of life for individuals living with SMI. Findings from this survey will inform NASMHPD guidance and recommendations. Survey responses will be aggregated and reported without attribution.
Please complete the survey by March 6th.
Please contact Elizabeth Hancq with any questions.